Skip to main content
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
9.86
+0.08 (0.82%)
Nov 13, 2026, 4:00 PM EST - Market closed

Contineum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
387418378---
Market Cap Growth
15.67%10.56%----
Enterprise Value
149241164---
Last Close Price
9.8611.4314.65---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.581.601.91---
P/TBV Ratio
1.581.601.91---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.030.010.150.08
Debt / EBITDA Ratio
---0.03--
Debt / FCF Ratio
---0.03--
Net Debt / Equity Ratio
-0.97-0.98-1.00-1.00-1.05-1.04
Net Debt / EBITDA Ratio
3.313.763.92-7.661.852.26
Net Debt / FCF Ratio
4.564.595.95-6.582.052.42
Asset Turnover
---0.55--
Quick Ratio
30.4526.9820.5322.836.2618.78
Current Ratio
31.1127.5020.6923.296.4118.99
Return on Equity (ROE)
-29.80%-26.13%-26.19%27.71%-48.09%-
Return on Assets (ROA)
-20.21%-17.38%-18.54%11.10%-23.44%-
Return on Capital Employed (ROCE)
-29.10%-25.50%-25.10%12.90%-52.70%-42.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.87%-14.37%-11.19%---
FCF Yield
-13.49%-13.30%-8.83%---
Buyback Yield / Dilution
-36.25%-43.14%-469.95%-51.38%-6.35%-
SEC Filings: 10-K · 10-Q